iRhythm Technologies Inc (IRTC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, iRhythm Technologies Inc (IRTC) has a cash flow conversion efficiency ratio of -0.162x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-26.17 Million) by net assets ($161.21 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of iRhythm Technologies Inc to measure how many days the company can operate on defensive assets alone.
iRhythm Technologies Inc - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how iRhythm Technologies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
iRhythm Technologies Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of iRhythm Technologies Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Innodata Inc
NASDAQ:INOD
|
0.291x |
|
Fattal 1998 Holdings Ltd
TA:FTAL
|
-0.022x |
|
Guangdong HongDa Blasting Co Ltd
SHE:002683
|
0.001x |
|
Viking Therapeutics Inc
NASDAQ:VKTX
|
-0.133x |
|
Zhuhai Bojay Electronics Co Ltd
SHE:002975
|
0.010x |
|
Zhejiang Taotao Vehicles Co. Ltd. A
SHE:301345
|
N/A |
|
Teleperformance SE
PA:TEP
|
0.220x |
|
Jiangsu Shemar Electric Co Ltd
SHG:603530
|
0.042x |
Annual Cash Flow Conversion Efficiency for iRhythm Technologies Inc (2013–2025)
The table below shows the annual cash flow conversion efficiency of iRhythm Technologies Inc from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see IRTC stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $152.75 Million | $80.86 Million | 0.529x | +1319.65% |
| 2024-12-31 | $90.91 Million | $3.39 Million | 0.037x | +115.64% |
| 2023-12-31 | $210.10 Million | $-50.10 Million | -0.238x | -148.51% |
| 2022-12-31 | $239.81 Million | $-23.01 Million | -0.096x | +28.95% |
| 2021-12-31 | $279.51 Million | $-37.75 Million | -0.135x | -235.35% |
| 2020-12-31 | $341.61 Million | $-13.76 Million | -0.040x | +75.05% |
| 2019-12-31 | $135.41 Million | $-21.86 Million | -0.161x | +69.77% |
| 2018-12-31 | $54.42 Million | $-29.07 Million | -0.534x | -184.96% |
| 2017-12-31 | $79.55 Million | $-14.91 Million | -0.187x | -4.19% |
| 2016-12-31 | $92.56 Million | $-16.65 Million | -0.180x | -201.53% |
| 2015-12-31 | $-101.62 Million | $-18.00 Million | 0.177x | +108.24% |
| 2014-12-31 | $7.26 Million | $-15.63 Million | -2.151x | +16.49% |
| 2013-12-31 | $4.60 Million | $-11.85 Million | -2.576x | -- |
About iRhythm Technologies Inc
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring s… Read more